top of page

Gastrointestinal Disease

Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease.

Cannabidiol in Inflammatory Bowel Diseases: A Brief Overview.

Cannabidiol Reduces Intestinal Inflammation through the Control of Neuroimmune Axis.

Cannabinoids and the gastrointestinal tract.

Cannabis Alleviates Symptoms of Crohn’s Disease.

Cannabis Finds Its Way into Treatment of Crohn's Disease.

Cannabis Induces a Clinical Response in Patients with Crohn's Disease: A Prospective Placebo-Controlled Study. 

​Cannabis use amongst patients with inflammatory bowel disease. 

Ghrelin and cannabinoids require the ghrelin receptor to affect cellular energy metabolism.

Marijuana Use Patterns Among Patients with Inflammatory Bowel Disease.

Pro-resolution, protective and anti-nociceptive effects of a cannabis extract in the rat gastrointestinal tract.

The effects of Δ9-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation andin vitromotility disturbances in rat colitis.

Treatment of Crohn's disease with cannabis: an observational study.

General

Acute Pulmonary Physiologic Effects of Smoked Marijuana and Oral Δ9-Tetrahydrocannabinol in Healthy Young Men.

Associations between adolescent cannabis use and neuropsychological decline: a longitudinal co-twin control study.

Cannabinoids in health and disease.

Cannabis and Eicosanoids: A Review of Molecular Pharmacology.

Cannabis sativa: The Plant of the Thousand and One Molecules.

Chemical constituents of marijuana: The complex mixture of natural cannabinoids.

Chemistry, metabolism, and toxicology of cannabis: clinical implications.

Early phytocannabinoid chemistry to endocannabinoids and beyond.

Future of Cannabis and Cannabinoids in Therapeutics.

Medical Marijuana: Clearing Away the Smoke.

Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb. 

Pharmacological actions and therapeutic uses of cannabis and cannabinoids.

Phytocannabinoids beyond the Cannabis plant - do they exist?

Plant cannabinoids: a neglected pharmacological treasure trove.

Review on clinical studies with cannabis and cannabinoids 2010-2014.

Therapeutic benefits of cannabis: a patient survey.

Therapeutic aspects of cannabis and cannabinoids.

Therapeutic benefits of cannabis: a patient survey.

Therapeutic potential of cannabis-related drugs.

Toward drugs derived from cannabis.

​Glioma

A Combined Preclinical Therapy of Cannabinoids and Temozolomide against Glioma.

Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism.

Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells.

Cannabinoids as potential new therapy for the treatment of gliomas.

Cannabinoids Inhibit Glioma Cell Invasion by Down-regulating Matrix Metalloproteinase-2 Expression.

Cannabinoids Inhibit the Vascular Endothelial Growth Factor Pathway in Gliomas.

Δ9-Tetrahydrocannabinol induces apoptosis in C6 glioma cells.

Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor.

Safety and efficacy of a novel cannabinoid chemotherapeutic, KM-233, for the treatment of high-grade glioma.

Systematic review of the literature on clinical and experimental trials on the antitumor effects of cannabinoids in gliomas.

The Combination of Cannabidiol and Δ9-Tetrahydrocannabinol Enhances the Anticancer Effects of Radiation in an Orthotopic Murine Glioma Model.

bottom of page